Healthcare / Health Information ServicesHKSE
$81.95
-1.80 (-2.15%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 23%
FCF escenarios
weak_data · normalized FCF $-167.2M · quality 68.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
25/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$9.9B
P/E
N/A
•EV/EBITDA
N/A
•ROE
-7.2%
↓Gross Margin
50.5%
↑Debt/Equity
0.32
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+24.7%
FCF CAGR
—
FCF margin
-17.1%
FCF / Net income
2.41x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $915.0M · net income $-64.8M · FCF $-156.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $915.0M | $915.0M | $734.0M | $556.1M | $471.9M |
| Net Income | $-64.8M | $-64.8M | $-132.6M | $-144.8M | $-208.6M |
| EBITDA | $-35.3M | $-35.3M | $-118.0M | $-143.7M | $-189.3M |
| EPS | -0.54 | -0.54 | -1.16 | -1.20 | -1.73 |
| Gross Margin | 50.5% | 50.5% | 55.1% | 56.6% | 48.9% |
| Operating Margin | -6.9% | -6.9% | -21.7% | -33.9% | -51.0% |
| Net Margin | -7.1% | -7.1% | -18.1% | -26.0% | -44.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.32 | 0.32 | 0.27 | 0.18 | 0.00 |
| Current Ratio | 1.41 | 1.41 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-156.4M | $-156.4M | $-167.2M | $-350.8M | $-129.0M |
| Returns | |||||
| ROE | -7.2% | -7.2% | -14.1% | -29.0% | -61.1% |
| Valuation | |||||
| P/B | 11.05 | 11.05 | 10.72 | — | — |
| Growth & Yield | |||||
| Revenue Growth | 24.7% | 24.7% | 32.0% | 17.9% | — |
| EPS Growth | 53.4% | 53.4% | 3.2% | 30.6% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-29.4%
Start / end P/E
n/dx → n/dx
EPS bridge
-1.16 → -0.54
Residual
-29.4%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.